1. Home
  2. TBLA vs NEO Comparison

TBLA vs NEO Comparison

Compare TBLA & NEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Taboola.com Ltd.

TBLA

Taboola.com Ltd.

HOLD

Current Price

$4.05

Market Cap

1.2B

Sector

Technology

ML Signal

HOLD

Logo NeoGenomics Inc.

NEO

NeoGenomics Inc.

HOLD

Current Price

$11.88

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBLA
NEO
Founded
2007
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Computer Software: Programming Data Processing
Precision Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
1999

Fundamental Metrics

Financial Performance
Metric
TBLA
NEO
Price
$4.05
$11.88
Analyst Decision
Strong Buy
Buy
Analyst Count
5
10
Target Price
$4.50
$12.56
AVG Volume (30 Days)
1.9M
1.8M
Earning Date
11-05-2025
10-28-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.08
N/A
Revenue
$1,880,771,000.00
$709,162,000.00
Revenue This Year
$11.25
$10.90
Revenue Next Year
$5.55
$9.88
P/E Ratio
$51.98
N/A
Revenue Growth
10.96
10.10
52 Week Low
$2.50
$4.72
52 Week High
$4.26
$19.12

Technical Indicators

Market Signals
Indicator
TBLA
NEO
Relative Strength Index (RSI) 56.84 60.77
Support Level $3.93 $11.59
Resistance Level $4.18 $12.26
Average True Range (ATR) 0.11 0.42
MACD -0.02 -0.07
Stochastic Oscillator 48.21 49.80

Price Performance

Historical Comparison
TBLA
NEO

About TBLA Taboola.com Ltd.

Taboola.com Ltd is a technology company that powers recommendations across the Open Web with an artificial intelligence-based, algorithmic engine. It partners with websites, devices, and mobile apps, collectively referred to as digital properties, to recommend editorial content and advertisements on the Open Web. Geographically it serves Israel, the United Kingdom, United States, Germany, Rest of the world. It generates the majority of its revenue from the United States.

About NEO NeoGenomics Inc.

NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.

Share on Social Networks: